3 weeks on tirzepatide no weight loss Long-Term and Maintenance | Ahmad Bahareth, MD posted the topic Tirzepatide Dosage Guide and Chart

Semaglutida : Conocido como Ozempic y Wegovy

About SURMOUNT-5 SURMOUNT-5 (NCT05822830) was a 72-week, multi-center, randomized, open-label, Phase 3b trial evaluating the efficacy and safety of Zepbound (tirzepatide) compared with Wegovy (semaglutide) in adults with obesity, or overweight with at least one of the following comorbidities: hypertension, dyslipidemia, obstructive sleep apnea (OSA) or cardiovascular disease, who did not have diabetes

In other words, starting low isnt less effective in the bigger picture

Evaluation of vitamin B12 deficiency among patients with type 2 diabetes mellitus on metformin at Hoima Regional Referral Hospital, Uganda